[Pulmonary zygomycosis in a patient treated for invasive aspergillosis]

S Tricot; T Gastine; B Sendid; A Wurtz; S de Botton; S Alfandari

doi:10.1016/j.medmal.2005.12.003

[Pulmonary zygomycosis in a patient treated for invasive aspergillosis]

Med Mal Infect. 2006 Feb;36(2):118-21. doi: 10.1016/j.medmal.2005.12.003. Epub 2006 Feb 3.

[Article in French]

Authors

S Tricot¹, T Gastine, B Sendid, A Wurtz, S de Botton, S Alfandari

Affiliation

¹ Service des maladies du sang, hôpital Huriez, CHRU, 59037 Lille, France.

PMID: 16458464
DOI: 10.1016/j.medmal.2005.12.003

Abstract

We report a pulmonary mucormycosis due to Absidia corymbifera. It occurred in a leukemic patient treated for a probable aspergillosis regressing after voriconazole treatment. The patient responded to surgery and a combination of liposomal amphotericin B and itraconazole. He was alive and well after 7-months of follow up.

Publication types

Case Reports

MeSH terms

Adult
Amphotericin B / therapeutic use
Antifungal Agents / therapeutic use
Aspergillosis / complications*
Drug Therapy, Combination
Humans
Itraconazole / therapeutic use
Leukemia / complications
Male
Radiography, Thoracic
Respiratory Tract Infections / diagnosis*
Respiratory Tract Infections / diagnostic imaging
Respiratory Tract Infections / drug therapy
Treatment Outcome
Zygomycosis / diagnosis*
Zygomycosis / diagnostic imaging
Zygomycosis / drug therapy

Substances

Antifungal Agents
Itraconazole
Amphotericin B